Last reviewed · How we verify
usual pain treatment — Competitive Intelligence Brief
phase 3
opioid
Pain management
Small molecule
Live · refreshed every 30 min
Target snapshot
usual pain treatment (usual pain treatment) — St. Olavs Hospital. Blocks pain signals to the brain.
Comparator set (6 drugs)
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| usual pain treatment TARGET | usual pain treatment | St. Olavs Hospital | phase 3 | opioid | ||
| Korsuva | DIFELIKEFALIN | Vifor Intl | marketed | Kappa Opioid Receptor Agonist | Kappa-type opioid receptor | 2021-01-01 |
| BENZHYDROCODONE | BENZHYDROCODONE | marketed | Opioid analgesic combination; full mu-opioid agonist with non-opioid analgesic | Mu-opioid receptors (primary); delta and kappa opioid receptors (secondary); central nervous system pain pathways | 2018-01-01 | |
| Symproic | NALDEMEDINE | Bdsi | marketed | Opioid Antagonist | Mu-type opioid receptor | 2017-01-01 |
| Viberzi | ELUXADOLINE | AbbVie | marketed | mu-Opioid Receptor Agonist [EPC] | Mu-type opioid receptor | 2015-01-01 |
| Movantik | NALOXEGOL | Averitas | marketed | Opioid Antagonist | Mu-type opioid receptor | 2014-01-01 |
| Nucynta | TAPENTADOL | Collegium Pharm Inc | marketed | Opioid Agonist | Mu-type opioid receptor | 2008-01-01 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (opioid class)
- Norwegian University of Science and Technology · 2 drugs in this class
- Cari Health Inc. · 1 drug in this class
- Cedars-Sinai Medical Center · 1 drug in this class
- Depomed · 1 drug in this class
- Mundipharma Pharmaceuticals B.V. · 1 drug in this class
- St. Olavs Hospital · 1 drug in this class
- Talphera, Inc · 1 drug in this class
- The Hospital for Sick Children · 1 drug in this class
- University of Monastir · 1 drug in this class
- University of Sao Paulo · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- usual pain treatment CI watch — RSS
- usual pain treatment CI watch — Atom
- usual pain treatment CI watch — JSON
- usual pain treatment alone — RSS
- Whole opioid class — RSS
Cite this brief
Drug Landscape (2026). usual pain treatment — Competitive Intelligence Brief. https://druglandscape.com/ci/usual-pain-treatment. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab